Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Oral pathogens" is a collective, non-specific term referring to microbial species (primarily bacteria) in the oral microbiome that cause oral diseases, such as dental caries and periodontitis. Key bacterial genera/species include *Porphyromonas gingivalis*, *Streptococcus mutans*, *Tannerella forsythia*, *Fusobacterium nucleatum*, and *Prevotella intermedia*, among others[1][2][3][4]. These pathogens contribute to disease by forming biofilms, evading immune responses, producing toxins, and driving tissue inflammation and destruction. Therapies may target these organisms individually or as part of their complex communities, but "oral pathogens" itself is not a molecular target and cannot be mapped to a single canonical protein or receptor[2][4][6][9]. In summary, "oral pathogens" improperly refers to a diverse group of pathogenic microbes and not a single targetable molecular entity. This makes it unsuitable for structured molecular target mapping, and it should be replaced by a precise molecular target (such as "Porphyromonas gingivalis major fimbriae" or "Streptococcus mutans glucosyltransferase") when aiming for drug discovery or target-based research[2][4][6].
Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis, targeting metabolic enzymes (e.g., pyruvate:ferredoxin oxidoreductase by amixicile), cell membrane disruption, bacteriophage-mediated lysis, bacteriocin-induced membrane perforation
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral pathogens.